LEONARD JOHN M

Director at IQVIA HOLDINGS INC. · on record since Apr 27, 2026
SVP, Chief Scientific Officer at AbbVie Inc. · on record since Dec 7, 2012
Director at CHIMERIX INC · on record since Jun 24, 2014
Director at QWEST COMMUNICATIONS INTERNATIONAL INC · on record since Feb 13, 2015
Director at Vitae Pharmaceuticals, Inc · on record since Jul 29, 2015
Director at Intellia Therapeutics, Inc. · on record since May 5, 2016
10% owner at Intellia Therapeutics, Inc. · on record since May 5, 2016
President and CEO at Intellia Therapeutics, Inc. · on record since May 15, 2018

Insider trading activity of LEONARD JOHN M

Transactions on record: 200; since Feb 19, 2013

Open-market buys: 2; $163.4K

Open-market sells: 65; $60.9M

Companies traded: 6; last filing Aug 24, 2026

Figures computed from official regulatory filings — .

Companies where LEONARD JOHN M has traded

Intellia Therapeutics, Inc.152 tx · $66.9M · Aug 24, 2026
IQVIA HOLDINGS INC.17 tx · $4.4M · Apr 27, 2026
CHIMERIX INC8 tx · $188.5K · Jun 29, 2017
QWEST COMMUNICATIONS INTERNATIONAL INC7 tx · May 25, 2017
Vitae Pharmaceuticals, Inc4 tx · $336.8K · Oct 25, 2016
AbbVie Inc.12 tx · $6.6M · Mar 19, 2013

Track record of LEONARD JOHN M

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of LEONARD JOHN M

Co-insiders of LEONARD JOHN M

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Intellia Therapeutics, Inc.Listing on record	Aug 24, 2026	Sell	-19,890	12.60 USD	$250.6K	SEC
Intellia Therapeutics, Inc.Listing on record	Aug 24, 2026	Sell	-2,785	13.00 USD	$36.2K	SEC
IQVIA HOLDINGS INC.Listing on record	Apr 27, 2026	Award	1,571	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Intellia Therapeutics, Inc.Listing on record	Mar 3, 2026	AwardD (derivative)	225,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Intellia Therapeutics, Inc.Listing on record	Mar 3, 2026	Award	156,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Intellia Therapeutics, Inc.Listing on record	Jan 7, 2026	Sell	-34,146	9.21 USD	$314.5K	SEC
Intellia Therapeutics, Inc.Listing on record	Dec 12, 2025	Sell	-5,355	9.59 USD	$51.4K	SEC
Intellia Therapeutics, Inc.Listing on record	Dec 12, 2025	ExerciseD (derivative)	-8,557	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Intellia Therapeutics, Inc.Listing on record	Dec 12, 2025	Exercise	8,557	6.83 USD	$58.4K	SEC
Intellia Therapeutics, Inc.Listing on record	Dec 12, 2025	ExerciseD (derivative)	-49,959	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Intellia Therapeutics, Inc.Listing on record	Dec 12, 2025	Sell	-32,832	9.47 USD	$310.9K	SEC
Intellia Therapeutics, Inc.Listing on record	Dec 12, 2025	Exercise	49,959	6.83 USD	$341.2K	SEC
Intellia Therapeutics, Inc.Listing on record	Dec 12, 2025	Sell	-49,959	9.49 USD	$474.1K	SEC
IQVIA HOLDINGS INC.Listing on record	Apr 25, 2025	Award	1,592	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Intellia Therapeutics, Inc.Listing on record	Mar 4, 2025	AwardD (derivative)	196,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Intellia Therapeutics, Inc.Listing on record	Mar 4, 2025	Award	136,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Intellia Therapeutics, Inc.Listing on record	Jan 7, 2025	Sell	-26,807	12.18 USD	$326.5K	SEC
Intellia Therapeutics, Inc.Listing on record	Jan 3, 2025	Exercise	7,850	—	n/a (No price was disclosed in the filing)	SEC
Intellia Therapeutics, Inc.Listing on record	Jan 3, 2025	ExerciseD (derivative)	-7,850	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
IQVIA HOLDINGS INC.Listing on record	May 9, 2024	Award	1,047	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Intellia Therapeutics, Inc.Listing on record	Mar 5, 2024	AwardD (derivative)	163,929	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Intellia Therapeutics, Inc.Listing on record	Mar 5, 2024	Award	113,586	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Intellia Therapeutics, Inc.Listing on record	Jan 5, 2024	Sell	-19,223	29.46 USD	$566.3K	SEC
Intellia Therapeutics, Inc.Listing on record	Jan 3, 2024	Exercise	7,848	—	n/a (No price was disclosed in the filing)	SEC
Intellia Therapeutics, Inc.Listing on record	Jan 3, 2024	ExerciseD (derivative)	-7,848	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Intellia Therapeutics, Inc.Listing on record	Aug 24, 2026	Sell	-19,890	12.60 USD	$250.6K	SEC
Intellia Therapeutics, Inc.Listing on record	Aug 24, 2026	Sell	-2,785	13.00 USD	$36.2K	SEC
IQVIA HOLDINGS INC.Listing on record	Apr 27, 2026	Award	1,571	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Intellia Therapeutics, Inc.Listing on record	Mar 3, 2026	AwardD (derivative)	225,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Intellia Therapeutics, Inc.Listing on record	Mar 3, 2026	Award	156,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Intellia Therapeutics, Inc.Listing on record	Jan 7, 2026	Sell	-34,146	9.21 USD	$314.5K	SEC
Intellia Therapeutics, Inc.Listing on record	Dec 12, 2025	Sell	-5,355	9.59 USD	$51.4K	SEC
Intellia Therapeutics, Inc.Listing on record	Dec 12, 2025	ExerciseD (derivative)	-8,557	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Intellia Therapeutics, Inc.Listing on record	Dec 12, 2025	Exercise	8,557	6.83 USD	$58.4K	SEC
Intellia Therapeutics, Inc.Listing on record	Dec 12, 2025	ExerciseD (derivative)	-49,959	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Intellia Therapeutics, Inc.Listing on record	Dec 12, 2025	Sell	-32,832	9.47 USD	$310.9K	SEC
Intellia Therapeutics, Inc.Listing on record	Dec 12, 2025	Exercise	49,959	6.83 USD	$341.2K	SEC
Intellia Therapeutics, Inc.Listing on record	Dec 12, 2025	Sell	-49,959	9.49 USD	$474.1K	SEC
IQVIA HOLDINGS INC.Listing on record	Apr 25, 2025	Award	1,592	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Intellia Therapeutics, Inc.Listing on record	Mar 4, 2025	AwardD (derivative)	196,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Intellia Therapeutics, Inc.Listing on record	Mar 4, 2025	Award	136,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Intellia Therapeutics, Inc.Listing on record	Jan 7, 2025	Sell	-26,807	12.18 USD	$326.5K	SEC
Intellia Therapeutics, Inc.Listing on record	Jan 3, 2025	Exercise	7,850	—	n/a (No price was disclosed in the filing)	SEC
Intellia Therapeutics, Inc.Listing on record	Jan 3, 2025	ExerciseD (derivative)	-7,850	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
IQVIA HOLDINGS INC.Listing on record	May 9, 2024	Award	1,047	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Intellia Therapeutics, Inc.Listing on record	Mar 5, 2024	AwardD (derivative)	163,929	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Intellia Therapeutics, Inc.Listing on record	Mar 5, 2024	Award	113,586	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Intellia Therapeutics, Inc.Listing on record	Jan 5, 2024	Sell	-19,223	29.46 USD	$566.3K	SEC
Intellia Therapeutics, Inc.Listing on record	Jan 3, 2024	Exercise	7,848	—	n/a (No price was disclosed in the filing)	SEC
Intellia Therapeutics, Inc.Listing on record	Jan 3, 2024	ExerciseD (derivative)	-7,848	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC